Oxford BioDynamics Plc
OBD.L · LSE
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | £0 | £0 | £0 | £0 |
| - Cash | £0 | £0 | £0 | £0 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £0 | £0 | £0 | £0 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | 72.2% | 24.7% | 231.2% | – |
| Gross Profit | -£0 | £0 | £0 | £0 |
| % Margin | -561.6% | 45.4% | 52.2% | 75.3% |
| EBITDA | -£0 | -£0 | -£0 | -£0 |
| % Margin | -895.1% | -1,614% | -1,929.6% | -3,999.4% |
| Net Income | -£0 | -£0 | -£0 | -£0 |
| % Margin | -1,018.5% | -1,818.7% | -2,122.7% | -4,357.1% |
| EPS Diluted | -0.008 | -0.045 | -0.073 | -0.067 |
| % Growth | 82.3% | 38.4% | -9.1% | – |
| Operating Cash Flow | -£0 | -£0 | -£0 | -£0 |
| Capital Expenditures | -£0 | -£0 | -£0 | -£0 |
| Free Cash Flow | -£0 | -£0 | -£0 | -£0 |